Ascendis Pharma A/S News

Cantor Fitzgerald Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $200

Moomoo NewsFeb 25 14:31 ET

Ascendis Pharma Analyst Ratings

BenzingaFeb 25 09:17 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $180

Moomoo NewsFeb 24 08:31 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $180 to $289

Moomoo NewsFeb 19 08:00 ET

Ascendis Pharma Is Maintained at Outperform by Evercore ISI Group

Dow JonesFeb 18 10:39 ET

Ascendis Pharma Analyst Ratings

BenzingaFeb 18 10:29 ET

Evercore Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $220

Moomoo NewsFeb 14 08:35 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $168 to $225

Moomoo NewsFeb 14 08:01 ET

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow JonesFeb 13 11:07 ET

Ascendis Pharma Analyst Ratings

BenzingaFeb 13 10:57 ET

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $162 to $289

Moomoo NewsFeb 13 08:02 ET

Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $181

Moomoo NewsFeb 11 13:31 ET

Cantor Fitzgerald Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $170

Moomoo NewsFeb 11 12:32 ET

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow JonesFeb 11 10:10 ET

Ascendis Pharma Analyst Ratings

BenzingaFeb 11 10:01 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Raises Target Price to $175

Moomoo NewsFeb 10 08:31 ET

Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $181

Moomoo NewsFeb 4 16:31 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsFeb 3 09:31 ET

Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167

Moomoo NewsJan 30 08:34 ET

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow JonesJan 29 08:12 ET